However, we know little about the potential role of the gut microbiota in CRC chemoresistance based on recent findings that the tumor microenvironment and fecal samples of CRC patients are enriched with Fn, which has been suggested as a risk factor for CRC development and progression [38]. The gene discussed is FN1; the disease is neoplasm.